Filed: 2/8/2024ACC: 0000950123-24-001156
📋 What this filing means
VERSANT VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $388.84M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$388.84M
Total AUM (reported)
24.21M
Total Shares
Allocation by class
COMMON STOCK$357.63M92.0%
COMMON SHARES$31.21M8.0%
Portfolio Concentration
Top 3$371.21M95.5%
4–10$17.63M4.5%
Top 3 weight
95.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 24.21M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
24.21M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other7
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings7
Rows:
RayzeBio, Inc.
OTRShares5.16M
TypeSH
Market value$320.68M
82.47%
Sole
0.00
Shared
5.16M
None
0.00
CRISPR Therapeutics AG
OTRShares498.56K
TypeSH
Market value$31.21M
8.03%
Sole
0.00
Shared
498.56K
None
0.00
Repare Therapeutics, Inc.
OTRShares2.65M
TypeSH
Market value$19.32M
4.97%
Sole
0.00
Shared
2.65M
None
0.00
Gritstone Bio, Inc.
OTRShares3.56M
TypeSH
Market value$7.26M
1.87%
Sole
0.00
Shared
3.56M
None
0.00
Passage Bio, Inc.
OTRShares4.96M
TypeSH
Market value$5.01M
1.29%
Sole
0.00
Shared
4.96M
None
0.00
Adverum Biotechnologies, Inc.
OTRShares5.07M
TypeSH
Market value$3.82M
0.98%
Sole
0.00
Shared
5.07M
None
0.00
Aligos Therapeutics, Inc.
OTRShares2.32M
TypeSH
Market value$1.54M
0.40%
Sole
0.00
Shared
2.32M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
RayzeBio, Inc.OTR | Common Stock | 5.16M | SH | $320.68M 82.47% | 0.00 | 5.16M | 0.00 |
CRISPR Therapeutics AGOTR | Common Shares | 498.56K | SH | $31.21M 8.03% | 0.00 | 498.56K | 0.00 |
Repare Therapeutics, Inc.OTR | Common Stock | 2.65M | SH | $19.32M 4.97% | 0.00 | 2.65M | 0.00 |
Gritstone Bio, Inc.OTR | Common Stock | 3.56M | SH | $7.26M 1.87% | 0.00 | 3.56M | 0.00 |
Passage Bio, Inc.OTR | Common Stock | 4.96M | SH | $5.01M 1.29% | 0.00 | 4.96M | 0.00 |
Adverum Biotechnologies, Inc.OTR | Common Stock | 5.07M | SH | $3.82M 0.98% | 0.00 | 5.07M | 0.00 |
Aligos Therapeutics, Inc.OTR | Common Stock | 2.32M | SH | $1.54M 0.40% | 0.00 | 2.32M | 0.00 |